What is NDC 51662-1310?

51662-1310 is the product NDC for Infant 4.2% Sodium Bicarbonate, Sodium bicarbonate 42 mg/mL injection, solution, listed with the FDA by HF Acquisition Co LLC, DBA HealthFirst. It has 2 package NDCs, shown above in 10- and 11-digit form.

HF Acquisition Co LLC, DBA HealthFirst, NDC labeler code 51662. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Infant 4.2% Sodium Bicarbonate?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Infant 4.2% Sodium Bicarbonate NDC 51662-1310

NDC codes

FDA NDC Directory

Product NDC (as listed)51662-1310Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51662-1310Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51662-1310-1	51662131001	10 mL in 1 SYRINGE (51662-1310-1)Marketed from Oct 21, 2018
51662-1310-3	51662131003	10 POUCH in 1 CASE (51662-1310-3) / 1 CARTON in 1 POUCH (51662-1310-2) / 1 SYRINGE in 1 CARTON / 10 mL in 1 SYRINGEMarketed from Jan 9, 2023

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Infant 4.2% Sodium Bicarbonate
Generic name (nonproprietary): infant 4.2% sodium bicarbonate
Active ingredients: Sodium bicarbonate — 42 mg/mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: HF Acquisition Co LLC, DBA HealthFirstNDC labeler code 51662
Product type: Prescription drug
Marketing category: Unapproved drug (other)
Marketing start: Oct 21, 2018
Listing expires: Dec 31, 2026
Other FDA classes: Alkalinizing Activity (Mechanism)
Identifiers: Product ID 51662-1310_37b6930c-c88f-4fd7-e063-6394a90a37f1SPL ID 37b6930c-c88f-4fd7-e063-6394a90a37f1SPL set ID 78c25911-0042-664e-e053-2a91aa0a57a1RxCUI 1868473UNII 8MDF5V39QO

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N451662131001 followed by a unit qualifier and the quantity

Package 51662-1310-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 16, 2025.

Indications (excerpt from the label)

INDICATIONS & USAGE Sodium Bicarbonate Injection, USP is indicated in the treatment of metabolic acidosis which may occur in severe renal disease, uncontrolled diabetes, circulatory insufficiency due to shock or severe dehydration, extracorporeal circulation of blood, cardiac arrest and severe primary lactic acidosis. Sodium bicarbonate is further indicated in the treatment of certain drug intoxications, including barbiturates (where dissociation of the barbiturate-protein complex is desired), in poisoning by salicylates or methyl alcohol and in hemolytic reactions requiring alkalinization of the urine to diminish nephrotoxicity of blood pigments. Sodium bicarbonate also is indicated in seve…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 51662-1310

What is NDC 51662-1310?: 51662-1310 is the product NDC for Infant 4.2% Sodium Bicarbonate, Sodium bicarbonate 42 mg/mL injection, solution, listed with the FDA by HF Acquisition Co LLC, DBA HealthFirst. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Infant 4.2% Sodium Bicarbonate.
What is the active ingredient?: Sodium bicarbonate.
Who is the labeler?: HF Acquisition Co LLC, DBA HealthFirst, NDC labeler code 51662. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Infant 4.2% Sodium Bicarbonate?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.